Genetic Hits and Mutation Rate in Colorectal Tumorigenesis: Versatility of Knudson's Theory and Implications for Cancer Prevention

Genes Chromosomes and Cancer

Volumn 38, Issue 4, 2003, Pages 382-388

  Bellacosa, Alfonso ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD2 PROTEIN;

ACCURACY; APC GENE; CANCER CELL; CANCER GENETICS; CANCER PREVENTION; COLON CARCINOGENESIS; COLORECTAL CANCER; EPITHELIUM TUMOR; GENE MUTATION; HUMAN; MUTATION RATE; ONCOGENE; ONCOGENE KRAS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; THEORY; TUMOR SUPPRESSOR GENE;

ADENOMA; COLORECTAL NEOPLASMS; HUMANS; MODELS, GENETIC; MUTATION;

EID: 0344155277     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10287     Document Type: Review

References (33)

1. Armitage P, Doll R. 1954. The age distribution of cancer and a multistage theory of carcinogenesis. Br J Cancer 8:1-12.
2. Armitage P, Doll R. 1957. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer 11:161-169.
3. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H. 2002. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111:251-263.
4. Boveri M. 1929. The origin of malignant tumors. Gustav Fischer J, translator. Baltimore: Williams and Wilkins. Translation of: Zur Frage der Entstehung maligner Tumoren (Boveri T, 1914).
5. Cairns J, Overbaugh J, Miller S. 1988. The origin of mutants. Nature 335:142-145.
6. Erikson J. 1996. Progress and challenges: 5 leaders in war on cancer assess impact of National Cancer Act of 1971. Oncology Times 18:1-37.
7. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
8. Fishel R. 1999. Signaling mismatch repair in cancer. Nat Med 5:1239-1241.
9. Fodde R, Smits R, Clevers H. 2001. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1:55-67.
10. Gisselsson D, Pettersson L, Hoglund M, Heidenblad M, Gorunova L, Wiegant J, Mertens F, Dal Cin P, Mitelman F, Mandahl N. 2000. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 97:5357-5362.
11. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
12. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
13. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, Zheng S, Willson JK, Markowitz SD, Morin P, Kinzler KW, Vogelstein B, Dunlop MG. 1996. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA 93:9049-9054.
14. Jallepalli PV, Lengauer C. 2001. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 1:109-117.
15. Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170.
16. Kinzler KW, Vogelstein B. 1997. Cancer-susceptibility genes. Gate-keepers and caretakers. Nature 386:761-763.
17. Knudson AG. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
18. Knudson AG. 2001. Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157-162.
19. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784-1787.
20. Lengauer C, Kinzler KW, Vogelstein B. 1997. Genetic instability in colorectal cancers. Nature 386:623-627.
21. Loeb LA. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079.
22. Loeb LA, Loeb KR, Anderson JP. 2003. Multiple mutations and cancer. Proc Natl Acad Sci USA 100:776-781.
23. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790.
24. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
25. Rasnick D, Duesberg PH. 1999. How aneuploidy affects metabolic control and causes cancer. Biochem J 340:621-630.
26. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. 1997. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792.
27. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. 2001. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61:818-822.
28. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR. 2002. Mutations in APC, Kirstenras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 99:9433-9438.
29. Stock RP, Bialy H. 2003. The sigmoidal curve of cancer. Nat Biotechnol 21:13-14.
30. Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, Anderson GR. 1999. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 96:15121-15126.
31. Tomlinson I, Bodmer W. 1999. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med 5:11-12.
32. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. 2002. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009.
33. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241-250.